Couverture de Hope in a Dose: Cell & Gene Therapy

Hope in a Dose: Cell & Gene Therapy

Hope in a Dose: Cell & Gene Therapy

De : Fortrea
Écouter gratuitement

À propos de ce contenu audio

 Welcome to Hope in a Dose—the podcast where we explore the science, strategy, and stories behind the therapies redefining what’s possible. Designed for CGT innovators, this series helps you move smarter, faster, and with greater operational confidence. Across each episode, we unpack the real-world challenges sponsors face today: selecting truly CGT-capable sites, navigating early-phase risk, activating global trials in rare populations, and demonstrating meaningful clinical impact. Hosted by Lousie Kearney Head of Cell and Gene Therapy, Strategy and Delivery at Fortrea, a seasoned leader with decades of experience guiding emerging biotechs, Hope in a Dose equips CGT innovators, clinical sites, and Principal Investigators with practical tools to navigate the unique complexities of advanced therapy development.
Épisodes
  • Hope in a Dose | Ep 1 | Breaking Ground: What Makes CGT Phase Trials Different

    Hope in a Dose | Ep 1 | Breaking Ground: What Makes CGT Phase Trials Different
    Apr 6 2026
    Discover what sets cell and gene therapy (CGT) clinical trials apart. From “one-and-done” treatments to complex logistics and evolving regulations, our first episode of this podcast series explores the unique challenges and transformative potential of CGT studies. Join us as we dive into science, strategy, and stories behind Hope in a Dose.
    Afficher plus Afficher moins
    8 min
  • Hope in a Dose | Ep 2 | CGT in Pediatric Patient Population

    Hope in a Dose | Ep 2 | CGT in Pediatric Patient Population
    Apr 6 2026
    Today we're diving into one of the most exciting frontiers in medicine: cell and gene therapy for pediatric diseases. Why is it so important? Part of the answer lies in the fact that cell and gene therapy offers something extraordinary: a cure, not just symptom management. In this episode hear from leading experts about the science, challenges, and human impact of pediatric CGT clinical trials. Join us as we discuss the evolving landscape, regulatory considerations, and the importance of community support in transforming lives. Listen now to “Hope in a Dose” and learn how science is turning hope into reality for children and families worldwide.
    Afficher plus Afficher moins
    15 min
  • Hope in a Dose | Ep 3 | Partners in Scale: CDMOs and CROs Working as One

    Hope in a Dose | Ep 3 | Partners in Scale: CDMOs and CROs Working as One
    Apr 6 2026
    In this episode we will discuss topics that are critical to the success of CGT programs: seamless collaboration between CDMOs and CROs. In cell and gene therapy, complexity isn't just in science, it's in the execution. And that's where integrative thinking comes in, where manufacturing and clinical operations work as one, we can accelerate timelines, reduce risk, and optimize costs. In this episode, we'll explore how early alignment between CDMOs and CROs can transform technologies into opportunities, from protocol design to study chain logistics and overall project success. Learn how proactive coordination—from tech transfer and manufacturing to clinical operations and regulatory submissions—creates a unified strategy that drives success. Hear real-world insights on overcoming challenges, synchronizing supply chains, and delivering hope to patients faster through true partnership. Listen now to explore the power of working as one in advanced therapy trials.
    Afficher plus Afficher moins
    14 min
Aucun commentaire pour le moment